ORKA
Oruka Therapeutics Inc
$300.01M
Single sell
Discretionary Insider Activity
Date:
07/01/2026
Insiders:
Fairmount Funds Management LLC, director
Prior trend:
23 months of no clear discretionary insider activity

Summary

A $300.01M single sell for Oruka Therapeutics Inc (ORKA) on 07/01/2026 after 23 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Sell $300.01M 07/01/2026 Fairmount Funds Management LLC + 7 Director, a 10%+ owner 0001104659-26-080009

Stake Changes

Action Insider Role(s) Total Change % Change
Fairmount Funds Management LLC Director, a 10%+ owner unknown unknown

Transactions

Action Amount Date Insider Security Type SEC Code
– 07/01/2026 Fairmount Funds Management LLC Series B Preferred Stock Non-discretionary Conversion
– 07/01/2026 Fairmount Funds Management LLC Common Stock Non-discretionary Conversion
Sell $300.01M 07/01/2026 Fairmount Funds Management LLC Common Stock Discretionary Sale

Stats

Prior max multiple:
141.1
Prior median multiple:
213.2

Metadata

Signal ID:
btFYsdNpF3IEc0BG
Scanned on:
07/01/2026
Status:
Current